In conclusions, insulin treatment in type 2 diabetes was closely associated with increased risk of carotid atherosclerotic lesions, which partly attributed to severe insulin resistance in patients receiving insulin therapy. The gene discussed is INS; the disease is type 2 diabetes mellitus.